Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis

Arthritis Research and Therapy

Volumn 11, Issue 2, 2009, Pages

  Hannawi, Suad ^a   Marwick, Thomas H ^a   Thomas, Ranjeny ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY INTIMA; ARTERY LESION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW MEDIATED DILATATION; GLYCERYL TRINITRATE MEDIATED DILATATION; HUMAN; INFLAMMATION; MALE; RHEUMATOID ARTHRITIS; ULTRASOUND; CIRCULATION; ECHOGRAPHY; INTIMA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOOD CIRCULATION; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CAROTID ARTERIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; TUNICA INTIMA;

EID: 65849498379     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2668     Document Type: Article

References (52)

1. del Rincon ID Williams K Stern MP Freeman GL Escalante A High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 2001, 44:2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# 11762933
2. Wolfe F Mitchell DM Sibley JT Fries JF Bloch DA Williams CA Spitz PW Haga M Kleinheksel SM Cathey MA The mortality of rheumatoid arthritis Arthritis Rheum 1994, 37:481-494. 10.1002/art.1780370408 8147925
3. Banks M Flint J Bacon P Kitas G Rheumatoid arthritis is an independent risk factor for ischaemic heart disease Arthritis Rheum 2000, 1909:S358.
4. Lutzky V Hannawi S Thomas R Cells of the synovium in rheumatoid arthritis. Dendritic cells Arthritis Res Ther 2007, 9:219. 2206384 17850683 10.1186/ar2200
5. Pignoli P Tremoli E Poli A Oreste P Paoletti R Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging Circulation 1986, 74:1399-1406. 3536154
6. Lorenz MW Markus HS Bots ML Rosvall M Sitzer M Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis Circulation 2007, 115:459-467. 10.1161/ CIRCULATIONAHA.106.628875 17242284
7. Salonen JT Salonen R Ultrasound B-mode imaging in observational studies of atherosclerotic progression Circulation 1993, 87:II56-65. 8443925
8. Hannawi S Haluska B Marwick TH Thomas R Atherosclerotic disease is increased in recent onset rheumatoid arthritis: A critical role for inflammation Arthritis Res Ther 2007, 9:R116. 2246234 17986352 10.1186/ ar2323
9. Raitakari OT Seale JP Celermajer DS Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis Am J Cardiol 2001, 87:217-219. A218. 10.1016/S0002-9149(00)01321-7 11152844
10. Joannides R Haefeli WE Linder L Richard V Bakkali EH Thuillez C Luscher TF Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo Circulation 1995, 91:1314-1319. 7867167
11. Corretti MC Anderson TJ Benjamin EJ Celermajer D Charbonneau F Creager MA Deanfield J Drexler H Gerhard-Herman M Herrington D Vallance P Vita J Vogel R Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 2002, 39:257-265. 10.1016/S0735-1097(01)01746-6 11788217
12. Adams MR Robinson J McCredie R Seale JP Sorensen KE Deanfield JE Celermajer DS Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis J Am Coll Cardiol 1998, 32:123-127. 10.1016/S0735-1097(98)00206-X 9669259
13. Bergholm R Leirisalo-Repo M Vehkavaara S Makimattila S Taskinen MR Yki-Jarvinen H Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis Arterioscler Thromb Vasc Biol 2002, 22:1637-1641. 10.1161/01.ATV.0000033516.73864.4E 12377742
14. Gonzalez-Juanatey C Testa A Garcia-Castelo A Garcia-Porrua C Llorca J Gonzalez-Gay MA Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 2004, 51:447-450. 10.1002/art.20407 15188332
15. Modena MG Bonetti L Coppi F Bursi F Rossi R Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women J Am Coll Cardiol 2002, 40:505-510. 10.1016/S0735-1097(02)01976-9 12142118
16. Hansel S Lassig G Pistrosch F Passauer J Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity Atherosclerosis 2003, 170:177-180. 10.1016/ S0021-9150(03)00281-8 12957697
17. Vaudo G Marchesi S Gerli R Allegrucci R Giordano A Siepi D Pirro M Shoenfeld Y Schillaci G Mannarino E Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity Ann Rheum Dis 2004, 63:31-35. 1754717 14672888 10.1136/ard.2003.007740
18. Cardillo C Schinzari F Mores N Mettimano M Melina D Zoli A Ferraccioli G Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis Clin Pharmacol Ther 2006, 80:275-281. 10.1016/j.clpt.2006.05.011 16952494
19. Hingorani AD Cross J Kharbanda RK Mullen MJ Bhagat K Taylor M Donald AE Palacios M Griffin GE Deanfield JE MacAllister RJ Vallance P Acute systemic inflammation impairs endothelium-dependent dilatation in humans Circulation 2000, 102:994-999. 10961963
20. Raza K Thambyrajah J Townend JN Exley AR Hortas C Filer A Carruthers DM Bacon PA Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: Lessons for atherosclerotic disease? Circulation 2000, 102:1470-1472. 11004134
21. Lima DS Sato EI Lima VC Miranda F Jr Hatta FH Brachial endothelial function is impaired in patients with systemic lupus erythematosus J Rheumatol 2002, 29:292-297. 11842823
22. Sari I Okan T Akar S Cece H Altay C Secil M Birlik M Onen F Akkoc N Impaired endothelial function in patients with ankylosing spondylitis Rheumatology (Oxford) 2006, 45:283-286. 10.1093/rheumatology/kei145 16204374
23. Carroll L Hannawi S Marwick T Thomas R Rheumatoid arthritis: Links with cardiovascular disease and the receptor for advanced glycation end products Wien Med Wochenschr 2006, 156:42-52. 10.1007/s10354-005-0242-9 16465613
24. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS, et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302 3358796
25. O'Dell JR Haire CE Erikson N Drymalski W Palmer W Eckhoff PJ Garwood V Maloley P Klassen LW Wees S Klein H Moore GF Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications N Engl J Med 1996, 334:1287-1291. 10.1056/NEJM199605163342002 8609945
26. Proudman SM Keen HI Stamp LK Lee AT Goldblatt F Ayres OC Rischmueller M James MJ Hill CL Caughey GE Cleland LG Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use Semin Arthritis Rheum 2007, 37:99-111. 10.1016/j.semarthrit.2007.02.001 17391739
27. Roberts LJ Cleland LG Thomas R Proudman SM Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis Med J Aust 2006, 184:122-125. 16460297
28. Saunders SA Capell HA Stirling A Vallance R Kincaid W McMahon AD Porter DR Triple therapy in early active rheumatoid arthritis: A randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies Arthritis Rheum 2008, 58:1310-1317. 10.1002/art.23449 18438851
29. Kooij van der SM Allaart CF Dijkmans BA Breedveld FC Innovative treatment strategies for patients with rheumatoid arthritis Curr Opin Rheumatol 2008, 20:287-294. 10.1097/BOR.0b013e3282fa13db 18388520
30. Raitakari OT Celermajer DS Flow-mediated dilatation Br J Clin Pharmacol 2000, 50:397-404. 2014404 11069434 10.1046/j.1365-2125.2000.00277.x
31. Stata corp Stata statistical software: Release 9.0 College station, Texas: Stata corp. LP 2005.
32. Wal van der AC Piek JJ de Boer OJ Koch KT Teeling P Loos van der CM Becker AE Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes Heart 1998, 80:14-18. 1728741 9764052
33. Pasceri V Yeh ET A tale of two diseases: Atherosclerosis and rheumatoid arthritis Circulation 1999, 100:2124-2126. 10571968
34. Ross R Atherosclerosis - an inflammatory disease N Engl J Med 1999, 340:115-126. 10.1056/NEJM199901143400207 9887164
35. Gabriel SE Crowson CS Kremers HM Doran MF Turesson C O'Fallon WM Matteson EL Survival in rheumatoid arthritis: A population-based analysis of trends over 40 years Arthritis Rheum 2003, 48:54-58. 10.1002/ art.10705 12528103
36. Van Doornum S McColl G Jenkins A Green DJ Wicks IP Screening for atherosclerosis in patients with rheumatoid arthritis: Comparison of two in vivo tests of vascular function Arthritis Rheum 2003, 48:72-80. 10.1002/art.10735 12528106
37. Datta D Ferrell WR Sturrock RD Jadhav ST Sattar N Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis Atherosclerosis 2007, 192:391-395. 10.1016/ j.atherosclerosis.2006.05.034 16806231
38. Galarraga B Khan F Kumar P Pullar T Belch JJ C-reactive protein: The underlying cause of microvascular dysfunction in rheumatoid arthritis Rheumatology (Oxford) 2008, 47:1780-1784. 10.1093/rheumatology/ken386 18854346
39. Quinn MA Emery P Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention Clin Exp Rheumatol 2003, 21:S154-157. 14969068
40. Anderson JJ Wells G Verhoeven AC Felson DT Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration Arthritis Rheum 2000, 43:22-29. 10.1002/ 1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9 10643696
41. Landewe RB Boers M Verhoeven AC Westhovens R Laar van de MA Markusse HM van Denderen JC Westedt ML Peeters AJ Dijkmans BA Jacobs P Boonen A Heijde van der DM Linden van der S COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention Arthritis Rheum 2002, 46:347-356. 10.1002/art.10083 11840436
42. Puolakka K Kautiainen H Mottonen T Hannonen P Korpela M Julkunen H Luukkainen R Vuori K Paimela L Blafield H Hakala M Leirisalo-Repo M Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial Arthritis Rheum 2004, 50:55-62. 10.1002/art.11436 14730599
43. Gonzalez-Juanatey C Llorca J Martin J Gonzalez-Gay MA Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis Semin Arthritis Rheum 2009, 38:366-371. 10.1016/j.semarthrit.2008.01.012 18336869
44. Maki-Petaja KM Booth AD Hall FC Wallace SM Brown J McEniery CM Wilkinson IB Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis J Am Coll Cardiol 2007, 50:852-858. 10.1016/j.jacc.2007.04.076 17719471
45. Bosello S Santoliquido A Zoli A Di Campli C Flore R Tondi P Ferraccioli G TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis Clin Rheumatol 2008, 27:833-839. 10.1007/s10067-007-0803-y 18075712
46. Gonzalez-Juanatey C Llorca J Vazquez-Rodriguez TR Diaz-Varela N Garcia-Quiroga H Gonzalez-Gay MA Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy Arthritis Rheum 2008, 59:1821-1824. 10.1002/art.24308 19035415
47. Choi HK Hernan MA Seeger JD Robins JM Wolfe F Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study Lancet 2002, 359:1173-1177. 10.1016/S0140-6736(02)08213-2 11955534
48. Gonzalez-Juanatey C Llorca J Testa A Revuelta J Garcia-Porrua C Gonzalez-Gay MA Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease Medicine (Baltimore) 2003, 82:407-413. 10.1097/01.md.0000101572.76273.60 14663290
49. Kerekes G Szekanecz Z Der H Sandor Z Lakos G Muszbek L Csipo I Sipka S Seres I Paragh G Kappelmayer J Szomjak E Veres K Szegedi G Shoenfeld Y Soltesz P Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: A multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity J Rheumatol 2008, 35:398-406. 18203326
50. Celermajer DS Sorensen KE Spiegelhalter DJ Georgakopoulos D Robinson J Deanfield JE Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women J Am Coll Cardiol 1994, 24:471-476. 8034885
51. Murohara T Kugiyama K Ohgushi M Sugiyama S Yasue H Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF Am J Physiol 1994, 266:H874-880. 8160834
52. Sanderson KJ van Rij AM Wade CR Sutherland WH Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease Atherosclerosis 1995, 118:45-51. 10.1016/ 0021-9150(95)05591-J 8579630